Tissue-indepedent cancer drug gets fast-track approval from US regulator
Wednesday, May 24, 2017 - 17:02
in Health & Medicine
Treatment will be given to patients based on a tumour’s molecular markers, rather than its location in the body.Nature News doi: 10.1038/nature.2017.22054